Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
ConditionCardiac Amyloidosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age80+
SponsorGérond'if
About this trial
Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography
Eligibility criteria
Qualifiers
Aged ≥ 80 years
Hospitalised for decompensation of heart failure in the last 12 months
Subjects with hypertrophy of the septum or left ventricle at cardiac echography (defined as ≥ 12 mm)
Subjects able to undergo a bone scintigraphy scan
Disqualifiers
Subjects refusing to participate
Subjects admitted to palliative care unit.
Subjects under guardianship
Subjects with a definite diagnosis of cardiac amyloidosis
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov